Sotera Health annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Sotera Health Stock-Based Compensation Growth & History (SHC)
Sotera Health's stock-based compensation was $30.9M for fiscal 2025.
View full Sotera Health company overviewSotera Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30.9M | −$5.9M | −16.04% |
| 2024 | 2024-12-31 | $36.8M | $4.5M | +14.08% |
| 2023 | 2023-12-31 | $32.2M | $11.0M | +51.99% |
| 2022 | 2022-12-31 | $21.2M | $7.3M | +52.93% |
| 2021 | 2021-12-31 | $13.9M | $2.9M | +26.24% |
| 2020 | 2020-12-31 | $11.0M | $4.1M | +59.65% |
| 2019 | 2019-12-31 | $6.9M | — | — |
Sotera Health quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.2M | −$901,000 | −11.10% |
| Q1 2026 | 2026-03-31 | $14.4M | $7.2M | +98.74% |
| Q4 2025 | 2025-12-31 | $7.6M | −$576,000 | −7.07% |
| Q3 2025 | 2025-09-30 | $7.9M | −$1.8M | −18.80% |
| Q2 2025 | 2025-06-30 | $8.1M | −$2.1M | −20.25% |
| Q1 2025 | 2025-03-31 | $7.2M | −$1.4M | −16.40% |
| Q4 2024 | 2024-12-31 | $8.1M | −$60,000 | −0.73% |
| Q3 2024 | 2024-09-30 | $9.8M | $1.4M | +16.91% |
| Q2 2024 | 2024-06-30 | $10.2M | $1.8M | +21.59% |
| Q1 2024 | 2024-03-31 | $8.7M | $1.4M | +18.87% |
| Q4 2023 | 2023-12-31 | $8.2M | $1.9M | +31.14% |
| Q3 2023 | 2023-09-30 | $8.4M | $3.8M | +81.39% |
| Q2 2023 | 2023-06-30 | $8.4M | $2.6M | +44.34% |
| Q1 2023 | 2023-03-31 | $7.3M | $2.8M | +60.60% |
| Q4 2022 | 2022-12-31 | $6.3M | $2.9M | +85.03% |
| Q3 2022 | 2022-09-30 | $4.6M | $1.1M | +30.14% |
| Q2 2022 | 2022-06-30 | $5.8M | $2.3M | +66.08% |
| Q1 2022 | 2022-03-31 | $4.5M | $1.1M | +31.57% |
| Q4 2021 | 2021-12-31 | $3.4M | −$3.6M | −51.48% |
| Q3 2021 | 2021-09-30 | $3.5M | $2.6M | +293.67% |
| Q2 2021 | 2021-06-30 | $3.5M | $2.1M | +150.75% |
| Q1 2021 | 2021-03-31 | $3.4M | $1.7M | +99.94% |
| Q4 2020 | 2020-12-31 | $7.0M | — | — |
| Q3 2020 | 2020-09-30 | $901,000 | — | — |
| Q2 2020 | 2020-06-30 | $1.4M | — | — |
| Q1 2020 | 2020-03-31 | $1.7M | — | — |
Sotera Health stock-based compensation trends
Over the last five fiscal years, Sotera Health's stock-based compensation increased from $11.0M to $30.9M, a change of $19.9M. The latest reported quarter, Q2 2026, shows $7.2M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sotera Health source filings ↗